Anavex Life Sciences Corp (AVXL)

[McMagyar]

I think it is a definitive possibility that patients after seeing the Monotherapy results requested/demanded to be put on Monotherapy. That is common sense and that is an adaptive trial.

They may not have, my point was how did the good Dr come to such definitive Data as to drop Anavex Plus as a target? My theory was that not only did Combo Therapy patients switch, but that those that did switch responded exceptionally well.

And that would be "coup des gras"
It could just be terrible data in the Combo bs good data in Monotherapy..
It's possible.. we find out soon..
Place your bets..